- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03942627
Promoting Maternal Mental Health and Wellbeing in Neonatal Intensive Care
Study Overview
Status
Intervention / Treatment
Detailed Description
An estimated 400,000-480,000 infants in the U.S. with serious medical conditions are cared for in neonatal intensive care units (NICUs) each year. Maternal stress exposure related to infants' NICU stays is an under-appreciated public health problem with negative implications for maternal and child health and wellbeing. Flexible, effective intervention strategies have potential to improve maternal mental health and parenting, promoting positive emotional and behavioral outcomes for both mothers and infants.
In the investigators' successful pilot research, the investigators developed an audio-delivered mindfulness program to help NICU mothers reduce rumination and worry, cultivate a state of calm awareness, and promote self care. In this small randomized pilot study, the investigators will randomly assign mothers with an infant in the neonatal intensive care unit (NICU) to receive either the mindfulness intervention or an active control program (audio-delivered education on infant care and development).
This study will evaluate feasibility of all key research aspects, including recruitment, randomization, intervention and control conditions, and assessments, in preparation for a future larger-scale study. This study will also assess preliminary intervention outcomes to identify potential program benefits.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- female
- 18 to 50 years old
- mother of an infant currently being treated in the Johns Hopkins Hospital or Johns Hopkins Bayview Medical Center NICU
- able to speak English
Exclusion Criteria:
- known to have serious psychopathology
- infant medically unstable/ progress is poor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness Program
The intervention consists of an introductory video in which a mindfulness expert explains the program's approach and models practices to increase women's comfort with the material, four audio-recorded mindfulness practices for mothers' use when the baby is in the NICU, each available in 5- and 10-minute versions, and a brief video and four additional audio mindfulness practices (each available in briefer and longer versions) for use by mothers during and following the transition home with the baby.
|
The intervention consists of two brief videos (one introducing the NICU portion of the program and one introducing the portion of the program addressing the transition home), as well as a series of mindfulness practices delivered via audio recordings to assist mothers in managing stress during the NICU stay and another series for the transition home.
|
Placebo Comparator: Infant Health Education Program
The intervention consists of an introductory video explaining the program's approach, four audio recordings providing education about infant health and development, each available in 5- and 10-minute versions, and a brief video and four additional educational recordings (each available in briefer and longer versions) for use by mothers during and following the transition home with the baby.
|
The active control condition consists of two brief videos (one introducing the NICU portion of the program and one introducing the portion of the program addressing the transition home), as well as a series of audio recordings providing information on infant health and development for mothers to use during the NICU stay and another series for the transition home.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depressive symptoms as assessed by the Patient Health Questionnaire (PHQ)-8
Time Frame: 2 weeks
|
Self-reported depressive symptoms over the last 2 weeks.
Each of the 8 items is scored 0 (not at all) to 3 (nearly every day), yielding a total between 0 and 24.
Higher scores mean more depressive symptoms.
|
2 weeks
|
Anxiety symptoms as assessed by the Generalized Anxiety Disorder - 7 (GAD-7)
Time Frame: 2 weeks
|
Self-reported anxiety symptoms over the last 2 weeks.
Each of the 7 items is rated from 0 (not at all) to 3 (nearly every day), yielding a total between 0 and 21.
Higher scores mean more anxiety.
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trauma symptoms as assessed by the Stanford Acute Stress Reaction Questionnaire (SASRQ)
Time Frame: 2 weeks
|
31-item self-report measure of trauma symptoms.
Items 1-30 are rated from 0 (not experienced) to 5 (very often experienced).
Item 31 asks how many days symptoms were experienced since giving birth, ranging from no days to 5 or more days.
Higher scores mean more frequent experience of trauma symptoms.
|
2 weeks
|
Perceived stress as assessed by the Perceived Stress Scale - NICU (PSS-NICU)
Time Frame: Up to 2 weeks
|
Self-report measure of perceived stress related to the NICU containing 4 sub scales, each with items rated on a scale of 1 (not at all stressful) to 5 (very stressful).
Higher scores mean more stress.
|
Up to 2 weeks
|
Sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 4 weeks
|
Self-reported measure assessing sleep quality
|
4 weeks
|
Coping as assessed by the Brief Cope Scale
Time Frame: Up to 2 weeks
|
28-item self-reported measure of coping strategies.
Items are rated on a scale ranging from 1 ("I usually don't do this at all") to 4 ("I usually do this a lot")
|
Up to 2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Erica Sibinga, M.D., Ph.D., Johns Hopkins University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00159072
- R34AT009615 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
Clinical Trials on Mindfulness Program
-
Universidad Miguel Hernandez de ElcheUniversidad Complutense de MadridRecruitingBurnout, Student | Mental Health Wellness | University Students | Occupational BalanceSpain
-
The Hospital for Sick ChildrenRecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea (Moderate to Severe)Canada
-
Northwestern UniversityNorthShore University HealthSystemCompletedProstate CancerUnited States
-
Northwestern UniversityCompleted
-
National Taipei University of Nursing and Health...Recruiting
-
University of California, San FranciscoMental Insight FoundationActive, not recruiting
-
Universidad de GranadaCompleted
-
Hong Kong Metropolitan UniversityCompleted
-
Vanderbilt University Medical CenterTerminatedPain | Back Pain | Low Back Pain | Chronic Low-back PainUnited States